Purpose: Spondylodiscitis is a rare infectious entity that requires multimodal diagnostic procedures. We evaluated the diagnostic performance of 18 F-FDG PET on suspected spondylodiscitis based on published literature. Patients and Methods: We searched the PubMed and EMBASE for pertinent studies up to July 2013. We implemented a patient-based meta-analysis of diagnostic data for FDG PET (the index test) against clinical, laboratory, and/or radiologic evidence of disease (the reference standard). A bivariate analysis was implemented to account for variability beyond the threshold effect. The individual patient data analysis was used to assess confounding factors that moderate diagnostic performance. Results: Twelve studies provided the diagnostic data on FDG PET and spondylodiscitis, comprising 224 patients. The combined sensitivity across studies was 0.97 [95% confidence interval (CI), 0.83Y1.00], the specificity was 0.88 (95% CI, 0.74Y0.95), and the area under the curve was 0.98 (95% CI, 0.96Y0.99). For prior probabilities greater than 0.50, the corresponding positive predictive value was 0.96 (0.93Y0.98), and the negative predictive value was 0.85 (0.82Y0.88). In the individual patient data analysis, metallic implants, dual PET/CT scanners and the addition of other imaging modalities to confirm disease were significant outcome moderators; only PET/CT remained significant in the adjusted analysis. PET/CT scanners improved the diagnostic performance, as opposed to the clinical data (age, sex, lesion site), which did not alter outcome. Conclusions: FDG PET is a robust diagnostic test when spondylodiscitis is suspected and is excellent for exclusion of infectious spondylodiscitis given its low likelihood ratio negative (G0.1). Importantly, this diagnostic test is unaffected by other confounders, including the presence of implants, when PET/ CT is used.
I
nfectious spondylodiscitis is a condition that includes spondylitis, discitis, and vertebral osteomyelitis and accounts for 2% to 4% of all bone infections. 1 Early diagnosis is very important because if it is treated in a timely fashion, mortality form spondylodiscitis is less than 5%. 2 However, early diagnosis of this infection is elusive, and it may take up to 4 to 8 weeks from the onset of symptoms, such as fever and back pain, and the development of radiographic abnormalities. 3, 4 Diagnosis depends on multiple modalities; it is achieved through a combination of imaging techniques, coupled with tissue histologic examination and bacterial cultures, thus frequently necessitating the need for biopsy. There has been great interest in imaging modalities given the traditionally invasive nature of the diagnosis. MRI is currently the imaging modality of choice, with a sensitivity of 96% and a specificity of 92%, 5 but it is limited in the setting of spinal implants and postoperative patients; furthermore, it may be difficult to differentiate infection from neoplasm and compression fractures. Other conventional radionuclide techniques, such as bone scintigraphy and 67 Ga, have been used with their respective disadvantages, which include false-negative results, persistence of findings after treating the infection, and inability to differentiate infection from postoperative changes. 6,7 18 F-FDG PET is a molecular imaging technique that originally had been used in oncologic cases but has been increasingly used to diagnose infection. FDG is a radiopharmaceutical that has increased uptake in metabolically active tissues as seen in malignancies. It also has increased uptake in the setting of infection and inflammation; this is thought to be due to the increased vascular permeability, the migration and increased metabolism of WBCs, and the increased expression of glucose transporters during an inflammatory response. 8Y10 Previously, studies have proven that FDG PET has diagnostic utility in diagnosing osteomyelitis, 11, 12 and there is an ongoing research regarding the role of FDG PET in diagnosing spondylodiscitis. This study is a diagnostic meta-analysis that aims to summarize the diagnostic performance of FDG PET when spondylodiscitis is suspected.
PATIENTS AND METHODS

Data Sources
We identified eligible studies by searching the PubMed and EMBASE. The search algorithm included PET, FDG PET, or positron, emission, and tomography, and diskitis, spondylodiskitis, discitis, spondylodiscitis, or osteomyelitis. We also ran a complementary hand search of reference lists of eligible studies and reviews. No language restriction was imposed. Abstracts, editorial materials, and conference proceedings were not considered. 
Data Extraction
Two authors (M.L.P. and P.D.Z.) determined the eligibility by title and abstract reading. The 2 authors retrieved potentially relevant articles in full text and assessed it for consistency with the eligibility criteria. In the case of a discrepancy, the decision to use a study was reached by consensus. Data on spondylodiscitis were extracted by the 2 authors and included patient demographics, site of inflammation, presence of implants, test characteristics (FDG PET, FDG PET/CT), and characteristics of the reference index.
Data Analysis
A diagnostic meta-analysis was performed to assess the performance of FDG PET in spondylodiscitis. We addressed the quality of studies using the revised QUADAS-2 (Quality Assessment of Diagnostic Accuracy Studies) tool. 13 Clinical, radiologic, and/or microbiologic/histologic proof of spondylodiscitis were considered as the reference index. We used patient-based data to construct the 2 Â 2 contingency tables and calculate the sensitivity and specificity for each individual study. True-positive, false-positive, true-negative, and false-negative observations were the components of the table based on the FDG PET classification and whether or not patients had documented spondylodiscitis. The pooled (combined) effects, namely sensitivity, specificity along with their 95% confidence contours, the likelihood ratio positive (LR+) and likelihood ratio negative (LRj), and the diagnostic accuracy (area under the curve, AUC) were calculated. 14Y16 An LR+ greater than 10 denotes that FDG PET is a good test for ruling in spondylodiscitis and an LRj less than 0.1 for ruling out spondylodiscitis. 14 We implemented a bivariate mixed-effect binomial regression model to account for within and between study variabilities. 17 The effects were presented by plotting the summary receiver operating characteristic curve with their corresponding 95% confidence contour. 14, 15, 18 This methodology is considered more appropriate when variability beyond the threshold effect is present, suggestive of statistical between-study heterogeneity. 19, 20 Formal tests of heterogeneity were not presented because they mislead systematic reviews of diagnostic accuracy data and therefore are not recommended. 21 Publication bias was assessed by the regression of the natural logarithm of diagnostic odds ratio against the square root of the effective sample size; P G 0.05 for the slope coefficient is suggestive of significant publication bias. 22 The MIDAS module of Stata commands was used for the meta-analysis of the diagnostic data. 17, 23 Finally, we performed an individual patient data (IPD) analysis of the raw data presented in the eligible studies. The aim was to assess significant modifiers of effect on the diagnosis of spondylodiscitis. Logistic regression models were constructed over the baseline model, which included the effect of FDG PET, by adding independent covariates (demographics, fused CT scanner, presence of implants, other imaging studies integrated in the reference index). The performance of each model was demonstrated by fitting the AUC as a measure of the model's ability to discriminate patients with spondylodiscitis from those without the infection. Nested models were compared for significant AUC differences using the roccomp Stata command. Stata version 11 (College Station, Tex) was used for data analysis. Significance level was set to 0.05.
RESULTS
A total of 189 articles from PubMed and 499 from EMBASE were initially retrieved, comprising a total of 544 nonduplicate publications. The last update was on July 24, 2013 (Fig. 1) . After reading the title and the abstract, 31 articles were found to be suitable for further evaluation. Of the 31 articles reviewed in detail, 21 were excluded [2 were reviews, 3 presented nonextractable data, 14 presented positive outcomes without negative results, 1 study was lesion based (looking at individual infections at different levels of the spine), and 1 had retrospective design with prior knowledge of the outcome], leaving 10 studies to be included in the final analysis.
1,12,24Y31 Three more articles, 32Y34 which were found upon performing a manual search of the references from the abovementioned studies, were included in the final analysis for a total of 13 articles. One article 26 was linked to a previous one 24 because of overlapping data, leaving a total of 12 studies coded from 13 articles ( Table 1 ).
The quality varied across included studies, (summary of quadas-2 quality data, Fig. 2) ; however, all had low to unclear risk of bias and applicability concerns, and therefore we did not exclude any from the analysis. Of note is that flow and timing was a concern in 3 studies given that reference index varied within the same study for the enrolled patients (which may expose to verification bias). 1, 27, 33 In addition, in 3 studies, dual PET/CT scanners were used 1, 29, 31 and may have influenced the diagnostic performance compared with PET scanners (the concern was related to the applicability of the index test). All studies included microbiologic/histologic documentation of positive cases; however, in 9 studies, 12, 24, 26, 28, 29 ,31Y34 the reference index did not integrate other imaging modalities, suggesting an unclear impact (potential source of bias related to the reference standard). The impact of these quality differences was resolved in the IPD analysis.
The median age across included study data varied from 27 to 65.5 years, with the proportion of male patients ranging from 39% to 78%. The prevalence of spondylodiscitis reached a cumulative of 48% (108/224) for IPD data. Twenty-one percent of patients (47/224) had implants and 79% did not. The sensitivity point estimates ranged from 0.82 to 1.00 across individual studies, and the specificity point estimates from 0.50 to 1.0 ( (Fig. 3) . When the diagnosis is strongly suspected, that is for a pretest probability of disease greater than 50%, the corresponding positive predictive value (PPV) was 0.96 (95% CI, 0.93Y0.98), whereas the negative predictive value (NPV) was 0.85 (95% CI, 0.82Y0.88). The overall performance of FDG PET is demonstrated in a pregraph/postgraph (Fig. 4) and is suggestive of the excellent performance of FDG PET in the diagnosis of infectious spondylodiscitis.
The IPD analysis and logistic regression models are displayed in Table 2 . The baseline model includes spondylodiscitis (the dependent outcome) and the result of FDG PET (as independent covariate). Adding demographics as independent covariates (age, sex) or the site of inflammation did not significantly affect outcome. The use of PET/CT scanners (model 5), the integration of other imaging modalities for disease confirmation (model 4), and the presence of implants (model 6) were significant effect modifiers. When effects were adjusted (model 7), only the impact of PET/CT remained significant. The comparisons of AUC values of nested models with significant effects confirmed that the diagnostic performance is optimized when PET/CT scanners are used (Table 3) .
DISCUSSION
We have performed a meta-analysis of diagnostic performance of FDG PET in the diagnosis of suspected spondylodiscitis. FDG PET was a reliable test to discriminate between those who have infectious spondylodiscitis and those who do not. The corresponding PPV and NPV were high, given a pretest probability of disease exceeding 50%. FDG PET has an excellent performance to exclude spondylodiscitis, given the very low LRj estimate (0.03). Interestingly, the diagnostic performance of FDG PET was not influenced by demographics or disease localization, and it remained unaffected to the variation of the reference standard, namely the inclusion of other imaging modalities, when PET/CT effect was considered.
The presence of metallic implants was a significant efficacy moderator and is presumably attributed to sterile inflammation occurring with prosthetic implants. More specifically, in the IPD data, false-positive studies were twice more frequent among cases with metallic implants (12.8%) compared with that in patients without (7.0%). Of note is that individual studies have given conflicting results. For example, de Winter et al 33 evaluated nontraumatic metallic implants and have found false-positive results in 6/30 (20%), which were attributed to sterile inflammation from prosthetic loosening. However, in the study by Schiesser et al, 34 false-positive findings were practically absent. One possible explanation is that differences in materials and treatment methodology (such as frequent external fixation performed in 34 ) as well as the setting (such as trauma patients that were the focus of 34 ) may account for differences between studies. The effect of implants weans for dual PET/CT scanners, which at present have become the modality of choice. PET/CT scanners add precise anatomic mapping, overcoming the relative absence of anatomic information with PET images alone, and distinguish vertebral infection from paravertebral tissue uptake. Moreover, although a direct comparison between MRI and FDG PET could not be derived from these data, FDG PET images can overcome the problem of artifacts when metallic implants are present.
Shortcomings include the limited number of studies and the small sample sizes. Moreover, differences in diagnostic accuracy related to the type of infection by causative agent could not be addressed because etiology was reported in a minority of studies and IPD data. Despite these limitations, our study provides substantial evidence that FDG PET is an excellent diagnostic tool when spondylodiscitis is suspected. Moreover, the FDG PET performance is further improved by dedicated PET/CT scanners, which may bypass limitations related to the presence of implants and obviate the need for additional imaging workup.
